Analyst Ratings (USA)
American analyst outlook currently reflects a selectively optimistic but increasingly cautious market outlook, with price target reductions significantly outnumbering increases. Technology, artificial intelligence, software, and selected financial services attracted favourable upgrades, while healthcare and biotechnology continued to generate interest through new coverage. However, commercial real estate, consumer-related industries, utilities, and certain financial companies faced downgrades and reduced valuations. Overall, analysts appeared increasingly focused on earnings resilience, valuation discipline, and sustainable growth amid continued economic uncertainty.
Updates (403)
A. O. Smith (AOS) — Longbow Research downgraded the stock from Buy to Neutral.
A. O. Smith (AOS) — Stifel downgraded the stock from Buy to Hold with a $59.00 price target.
Aardvark Therapeutics (AARD) — HC Wainwright maintained its Neutral rating and lowered its price target to $4.00 from $6.00.
Aardvark Therapeutics (AARD) — UBS Group set a $4.00 price target.
Abacus Global Management (ABX) — Piper Sandler maintained its Neutral rating and lowered its price target to $10.00 from $12.00.
ACADIA Pharmaceuticals (ACAD) — Needham & Company LLC maintained its Buy rating with a $35.00 price target.
Adagene (ADAG) — HC Wainwright maintained its Buy rating with a $7.00 price target.
Adagene (ADAG) — Stifel Nicolaus set a $7.00 price target.
Adient (ADNT) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $21.00 from $26.00.
Advanced Micro Devices (AMD) — TD Cowen maintained its Buy rating.
AeroVironment (AVAV) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $170.00 from $230.00.
AGCO (AGCO) — Barclays maintained its Underweight rating and lowered its price target to $97.00 from $105.00.
Agnico Eagle Mines (AEM) — Barclays maintained its Overweight rating and raised its price target to $218.00 from $188.00.
Agree Realty (ADC) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $79.00 from $83.00.
Air Canada (ACDVF) — Jefferies downgraded the stock from Hold to Underperform.
Alphabet (GOOG) — KeyCorp set a $410.00 price target.
Alphabet (GOOGL) — KeyCorp maintained its Overweight rating and lowered its price target to $410.00 from $435.00.
Alto Neuroscience (ANRO) — HC Wainwright maintained its Buy rating and raised its price target to $60.00 from $55.00.
Amazon.com (AMZN) — Morgan Stanley maintained its Overweight rating and raised its price target to $350.00 from $335.00.
Amazon.com (AMZN) — Yorkville Ives initiated coverage with a Outperform rating and a $300.00 price target.
AMC Entertainment (AMC) — B. Riley Financial maintained its Neutral rating.
Ameren (AEE) — Barclays maintained its Equal Weight rating and lowered its price target to $109.00 from $117.00.
American Axle & Manufacturing (DCH) — Stifel Nicolaus maintained its Hold rating and lowered its price target to $6.00 from $7.00.
American Electric Power (AEP) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $135.00 from $139.00.
American Electric Power (AEP) — Jefferies Financial Group set a $135.00 price target.
American Electric Power (AEP) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $135.00 from $140.00.
American Electric Power (AEP) — UBS Group set a $135.00 price target.
American Homes 4 Rent (AMH) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $34.00 from $38.00.
American Water Works (AWK) — Barclays maintained its Underweight rating and lowered its price target to $127.00 from $130.00.
Ameriprise Financial (AMP) — Bank of America downgraded the stock from Buy to Underperform with a $445.00 price target.
Amrize (AMRZ) — Barclays maintained its Equal Weight rating and lowered its price target to $40.00 from $55.00.
Apollo Global Management (APO) — Piper Sandler maintained its Overweight rating and lowered its price target to $145.00 from $159.00.
Arcutis Biotherapeutics (ARQT) — Guggenheim maintained its Buy rating and raised its price target to $44.00 from $38.00.
Ares Management (ARES) — Piper Sandler maintained its Overweight rating and lowered its price target to $143.00 from $150.00.
Athabasca Oil (ATHOF) — Jefferies downgraded the stock from Buy to Hold.
Atlassian (TEAM) — Guggenheim maintained its Buy rating and raised its price target to $280.00 from $165.00.
Atlassian (TEAM) — KeyCorp maintained its Overweight rating and raised its price target to $235.00 from $185.00.
Atlassian (TEAM) — UBS Group set a $280.00 price target.
Azul (AZUL) — The Goldman Sachs Group initiated coverage with a Neutral rating and a $8.10 price target.
Badger Meter (BMI) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $150.00 from $165.00.
Ball (BALL) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $70.00 from $72.00.
Baytex Energy (BTE) — Scotiabank maintained its Outperform rating.
Beauty Health (SKIN) — Jefferies Financial Group maintained its Hold rating and raised its price target to $11.00 from $0.85.
Bicara Therapeutics (BCAX) — BTIG Research maintained its Buy rating with a $39.00 price target.
BlackRock (BLK) — BMO Capital Markets maintained its Outperform rating and raised its price target to $1,350.00 from $1,300.00.
Blackstone (BX) — Piper Sandler maintained its Neutral rating and lowered its price target to $125.00 from $130.00.
Blue Owl Capital (OWL) — Piper Sandler maintained its Overweight rating and lowered its price target to $12.00 from $13.00.
Boyd Gaming (BYD) — Morgan Stanley upgraded the stock from Equal Weight to Overweight and lowered its price target to $83.00 from $89.00.
Boyd Gaming (BYD) — Susquehanna upgraded the stock from Neutral to Positive and lowered its price target to $83.00 from $87.00.
Boyd Gaming (BYD) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $86.00 from $87.00.
Brainsway (BWAY) — HC Wainwright maintained its Buy rating with a $19.00 price target.
BridgeBio Pharma (BBIO) — Piper Sandler maintained its Overweight rating and raised its price target to $120.00 from $115.00.
Bristol Myers Squibb (BMY) — Royal Bank Of Canada maintained its Sector Perform rating.
Brookfield Asset Management (BAM) — Piper Sandler set lowered its price target to $49.00 from $50.00 with a Neutral rating.
Brookfield Renewable (BEPC) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $32.00 from $36.00.
Brookfield Renewable Partners (BEP) — JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $32.00 from $36.00.
BXP (BXP) — Piper Sandler downgraded the stock from Overweight to Neutral with a $64.00 price target.
Camden Property Trust (CPT) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $103.00 from $110.00.
Cameco (CCJ) — Barclays maintained its Equal Weight rating and lowered its price target to $95.00 from $97.00.
Camping World (CWH) — Northcoast Research set a $11.00 price target.
Canadian Natural Resources (CNQ) — Scotiabank maintained its Sector Perform rating.
Cardinal Infrastructure Group (CDNL) — Truist Financial set a $30.00 price target.
CareDx (CDNA) — Canaccord Genuity Group maintained its Buy rating and raised its price target to $80.00 from $65.00.
CareTrust REIT (CTRE) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $43.00 from $44.00.
Caris Life Sciences (CAI) — Canaccord Genuity Group maintained its Hold rating and raised its price target to $30.00 from $22.00.
Carlyle Group (CG) — Piper Sandler maintained its Overweight rating and lowered its price target to $48.00 from $54.00.
Carter’s (CRI) — UBS Group maintained its Neutral rating with a $38.00 price target.
Celcuity (CELC) — Citigroup maintained its Market Outperform rating.
Cenovus Energy (CVE) — Scotiabank maintained its Outperform rating.
CenterPoint Energy (CNP) — Barclays maintained its Equal Weight rating and lowered its price target to $41.00 from $44.00.
CenterPoint Energy (CNP) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $45.00 from $48.00.
Centerspace (CSR) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $53.00 from $57.00.
Charles Schwab (SCHW) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $97.00 from $105.00.
Cheniere Energy (LNG) — Raymond James Financial maintained its Strong-Buy rating with a $340.00 price target.
Chesapeake Utilities (CPK) — Barclays set lowered its price target to $134.00 from $136.00 with a Equal Weight rating.
Choice Hotels International (CHH) — Wells Fargo & Company maintained its Underweight rating and raised its price target to $98.00 from $97.00.
Chord Energy (CHRD) — Roth Capital maintained its Buy rating with a $165.00 price target.
Churchill Downs (CHDN) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $120.00 from $117.00.
Cinemark (CNK) — B. Riley Financial maintained its Neutral rating.
Citizens (CIZN) — Citigroup reiterated coverage.
Citizens Financial Group (CFG) — DA Davidson set a $82.00 price target.
Citizens Financial Group (CFG) — Morgan Stanley maintained its Overweight rating and lowered its price target to $87.00 from $89.00.
Citizens Financial Group (CFG) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $74.00 from $79.00.
Clene (CLNN) — HC Wainwright maintained its Buy rating.
Cleveland-Cliffs (CLF) — Barclays maintained its Underweight rating and raised its price target to $11.00 from $10.00.
Clorox (CLX) — Deutsche Bank Aktiengesellschaft maintained its Hold rating with a $95.00 price target.
CMS Energy (CMS) — BMO Capital Markets maintained its Outperform rating and raised its price target to $76.00 from $73.00.
CNH Industrial (CNH) — Barclays maintained its Overweight rating and raised its price target to $14.00 from $12.00.
CocaCola (KO) — UBS Group maintained its Buy rating.
Cognizant Technology Solutions (CTSH) — Citigroup maintained its Neutral rating.
Colgate-Palmolive (CL) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $104.00 from $103.00.
Comcast (CMCSA) — Rosenblatt Securities maintained its Buy rating with a $31.00 price target.
Commercial Metals (CMC) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $73.00 from $75.00.
Commercial Metals (CMC) — Morgan Stanley maintained its Overweight rating and lowered its price target to $84.00 from $88.00.
Cooper-Standard (CPS) — Stifel Nicolaus maintained its Buy rating and lowered its price target to $32.00 from $53.00.
CoreWeave (CRWV) — Cantor Fitzgerald maintained its Overweight rating.
CoreWeave (CRWV) — Moffett Nathanson set a $89.00 price target.
CoreWeave (CRWV) — Sanford C. Bernstein upgraded the stock from Underperform to Market Perform.
CoreWeave (CRWV) — The Goldman Sachs Group upgraded the stock from Neutral to Buy with a $106.00 price target.
CorMedix (CRMD) — Needham & Company LLC maintained its Buy rating with a $15.00 price target.
Coty (COTY) — Jefferies Financial Group maintained its Buy rating and raised its price target to $2.95 from $2.40.
Crescent Biopharma (CBIO) — HC Wainwright maintained its Buy rating with a $36.00 price target.
Crescent Biopharma (CBIO) — UBS Group maintained its Buy rating with a $36.00 price target.
CRH (CRH) — Barclays maintained its Overweight rating and lowered its price target to $110.00 from $131.00.
Crown (CCK) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $126.00 from $127.00.
Crown Castle (CCI) — BMO Capital Markets maintained its Outperform rating with a $93.00 price target.
Cullinan Therapeutics (CGEM) — BTIG Research maintained its Buy rating with a $40.00 price target.
Cummins (CMI) — Barclays maintained its Overweight rating and lowered its price target to $675.00 from $760.00.
Curtiss-Wright (CW) — Stifel Nicolaus maintained its Hold rating and lowered its price target to $518.00 from $700.00.
Cytokinetics (CYTK) — HC Wainwright maintained its Buy rating with a $140.00 price target.
Datadog (DDOG) — Sanford C. Bernstein upgraded the stock from Market Perform to Outperform and raised its price target to $350.00 from $237.00.
Definium Therapeutics (DFTX) — Royal Bank Of Canada maintained its Outperform rating.
Disc Medicine (IRON) — BMO Capital Markets maintained its Outperform rating and raised its price target to $120.00 from $100.00.
Disc Medicine (IRON) — Cantor Fitzgerald maintained its Overweight rating and raised its price target to $170.00 from $125.00.
Disc Medicine (IRON) — Truist Financial set a $115.00 price target.
Disc Medicine (IRON) — Wedbush maintained its Outperform rating.
Dominion Energy (D) — Barclays maintained its Overweight rating and lowered its price target to $65.00 from $69.00.
Dow (DOW) — Bank of America upgraded the stock from Underperform to Neutral with a $31.00 price target.
DraftKings (DKNG) — Morgan Stanley maintained its Overweight rating and lowered its price target to $31.00 from $36.00.
DraftKings (DKNG) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $30.00 from $29.00.
e.l.f. Beauty (ELF) — Jefferies Financial Group maintained its Buy rating and raised its price target to $132.00 from $100.00.
e.l.f. Beauty (ELF) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $130.00 from $106.00.
Ellington Credit (EARN) — Piper Sandler maintained its Overweight rating and lowered its price target to $4.50 from $5.00.
Emerson Electric (EMR) — Morgan Stanley maintained its Underweight rating and raised its price target to $145.00 from $135.00.
Enliven Therapeutics (ELVN) — HC Wainwright maintained its Buy rating and raised its price target to $73.00 from $65.00.
Entergy (ETR) — Barclays maintained its Overweight rating and lowered its price target to $115.00 from $128.00.
Entrada Therapeutics (TRDA) — HC Wainwright maintained its Neutral rating.
Entrada Therapeutics (TRDA) — UBS Group maintained its Neutral rating.
EPR Properties (EPR) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $56.00 from $61.00.
Equifax (EFX) — Mizuho maintained its Outperform rating and lowered its price target to $185.00 from $210.00.
Equity Lifestyle Properties (ELS) — Wells Fargo & Company set lowered its price target to $64.00 from $69.00 with a Equal Weight rating.
ESAB (ESAB) — Stifel Nicolaus set a $114.00 price target.
Essential Properties Realty Trust (EPRT) — Mizuho maintained its Outperform rating and lowered its price target to $29.00 from $30.00.
Essential Properties Realty Trust (EPRT) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $30.00 from $36.00.
Essex Property Trust (ESS) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $279.00 from $297.00.
Estee Lauder Companies (EL) — Jefferies Financial Group maintained its Hold rating and raised its price target to $120.00 from $100.00.
Estee Lauder Companies (EL) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $115.00 from $112.00.
Evergy (EVRG) — Barclays maintained its Overweight rating and lowered its price target to $86.00 from $92.00.
Exagen (XGN) — Canaccord Genuity Group maintained its Buy rating and raised its price target to $11.00 from $9.00.
Exelixis (EXEL) — Citigroup maintained its Market Outperform rating.
Exelixis (EXEL) — Citizens Jmp maintained its Market Outperform rating and raised its price target to $65.00 from $55.00.
Exelon (EXC) — Barclays maintained its Equal Weight rating and lowered its price target to $44.00 from $49.00.
ExxonMobil (XOM) — Barclays maintained its Overweight rating and raised its price target to $200.00 from $177.00.
ExxonMobil (XOM) — UBS Group maintained its Buy rating with a $199.00 price target.
Eyepoint Pharmaceuticals (EYPT) — Guggenheim downgraded the stock from Buy to Neutral.
Eyepoint Pharmaceuticals (EYPT) — Jefferies Financial Group downgraded the stock from Buy to Hold with a $1.00 price target.
Fair Isaac (FICO) — Mizuho maintained its Outperform rating and lowered its price target to $1,063.00 from $1,344.00.
First Financial Bankshares (FFIN) — Piper Sandler maintained its Neutral rating and lowered its price target to $33.00 from $35.00.
First Horizon (FHN) — Truist Financial maintained its Hold rating and raised its price target to $26.00 from $25.00.
Floor & Decor (FND) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $45.00 from $55.00.
FMC (FMC) — Citigroup maintained its Neutral rating.
FormFactor (FORM) — B. Riley Financial maintained its Buy rating.
Fortune Brands Innovations (FBIN) — Citigroup maintained its Reduce rating.
Four Corners Property Trust (FCPT) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $22.00 from $26.00.
Fox Factory (FOXF) — B. Riley Financial maintained its Neutral rating.
Fox Factory (FOXF) — Roth Capital maintained its Neutral rating with a $17.00 price target.
Fractyl Health (GUTS) — Craig Hallum set a $5.00 price target.
Fractyl Health (GUTS) — Morgan Stanley maintained its Equal Weight rating with a $4.00 price target.
Freeport-McMoRan (FCX) — Barclays maintained its Overweight rating and raised its price target to $84.00 from $83.00.
FrontView REIT (FVR) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $20.00 from $23.00.
Gaming and Leisure Properties (GLPI) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $40.00 from $43.00.
GCM Grosvenor (GCMG) — Piper Sandler maintained its Overweight rating and lowered its price target to $14.50 from $16.00.
Gentherm (THRM) — Stifel Nicolaus set a $48.00 price target.
Global Payments (GPN) — KeyBanc upgraded the stock from Sector Weight to Overweight with a $105.00 price target.
Global Payments (GPN) — KeyCorp upgraded the stock from Sector Weight to Overweight with a $105.00 price target.
Global-E Online (GLBE) — Morgan Stanley upgraded the stock from Equal Weight to Overweight with a $50.00 price target.
GoDaddy (GDDY) — Cantor Fitzgerald maintained its Neutral rating and raised its price target to $100.00 from $90.00.
Grab (GRAB) — Barclays set a $4.00 price target.
Graphic Packaging (GPK) — Wells Fargo & Company maintained its Underweight rating and lowered its price target to $9.00 from $10.00.
Greif (GEF) — Wells Fargo & Company maintained its Cautious rating and lowered its price target to $88.00 from $90.00.
H2O America (HTO) — Barclays maintained its Overweight rating and lowered its price target to $65.00 from $66.00.
Hadron Energy (HDRN) — HC Wainwright initiated coverage with a Buy rating and a $4.50 price target.
Halliburton (HAL) — Piper Sandler maintained its Overweight rating and lowered its price target to $42.00 from $43.00.
Harmony Biosciences (HRMY) — Needham & Company LLC maintained its Buy rating with a $50.00 price target.
Healthcare Realty Trust (HR) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $18.00 from $20.00.
Healthpeak Properties (DOC) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $19.00 from $22.00.
Hexcel (HXL) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $97.00 from $110.00.
Hilton Grand Vacations (HGV) — Wells Fargo & Company maintained its Cautious rating and lowered its price target to $38.00 from $51.00.
Hilton Worldwide (HLT) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $383.00 from $382.00.
HIVE Digital Technologies (HIVE) — Canaccord Genuity Group maintained its Buy rating with a $10.00 price target.
Hudson Pacific Properties (HPP) — Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target to $13.00 from $15.00.
Hyatt Hotels (H) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $189.00 from $184.00.
IDEAYA Biosciences (IDYA) — Citigroup maintained its Market Outperform rating.
IDEX (IEX) — Stifel Nicolaus set a $267.00 price target.
Illumina (ILMN) — Canaccord Genuity Group maintained its Hold rating and raised its price target to $300.00 from $205.00.
Imperial Brands (IMBBY) — Jefferies downgraded the stock from Buy to Hold.
Independence Realty Trust (IRT) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $18.00 from $19.00.
Ingersoll Rand (IR) — Stifel Nicolaus set a $93.00 price target.
Intel (INTC) — Citigroup initiated coverage with a Buy ? Outperform rating.
Intel (INTC) — JPMorgan Chase & Co. upgraded the stock from Underweight to Neutral with a $85.00 price target.
Intel (INTC) — Morgan Stanley set a $85.00 price target.
Intel (INTC) — National Bank Financial set a $85.00 price target.
Intel (INTC) — Sanford C. Bernstein upgraded the stock from Market Perform to Outperform.
Intel (INTC) — Susquehanna upgraded the stock from Neutral to Positive.
Intel (INTC) — The Goldman Sachs Group initiated coverage with a Neutral rating.
Intuitive Surgical (ISRG) — TD Cowen maintained its Buy rating.
Invitation Home (INVH) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $30.00 from $33.00.
ITT (ITT) — Stifel Nicolaus set a $256.00 price target.
J.B. Hunt Transport Services (JBHT) — The Goldman Sachs Group maintained its Neutral rating with a $252.00 price target.
JAN (JAN) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $34.00 from $35.00.
Janux Therapeutics (JANX) — HC Wainwright maintained its Buy rating.
JetBlue Airways (JBLU) — UBS Group upgraded the stock from Sell to Neutral and lowered its price target to $3.50 from $4.00.
Jumia Technologies (JMIA) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $9.00 from $11.00.
Kinetik (KNTK) — Jefferies Financial Group maintained its Hold rating and lowered its price target to $54.00 from $56.00.
KKR & Co. Inc. (KKR) — Piper Sandler maintained its Overweight rating and lowered its price target to $121.00 from $128.00.
Kratos Defense & Security Solutions (KTOS) — Citigroup maintained its Market Outperform rating.
Kratos Defense & Security Solutions (KTOS) — Citizens Jmp maintained its Market Outperform rating and lowered its price target to $70.00 from $105.00.
Kratos Defense & Security Solutions (KTOS) — Jefferies Financial Group downgraded the stock from Buy to Negative.
Ladder Capital (LADR) — B. Riley Financial maintained its Buy rating.
Lam Research (LRCX) — Deutsche Bank Aktiengesellschaft maintained its Buy rating with a $375.00 price target.
LandBridge (LB) — Raymond James Financial maintained its Outperform rating with a $91.00 price target.
Las Vegas Sands (LVS) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $55.00 from $61.00.
Las Vegas Sands (LVS) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $44.00 from $48.00.
LCI Industries (LCII) — Stifel downgraded the stock from Buy to Hold with a $80.00 price target.
LENZ Therapeutics (LENZ) — Piper Sandler maintained its Neutral rating and lowered its price target to $5.00 from $7.00.
LGN (LGN) — Barclays maintained its Equal Weight rating and lowered its price target to $60.00 from $80.00.
Liberty Energy (LBRT) — Piper Sandler maintained its Overweight rating and lowered its price target to $29.00 from $30.00.
Liftoff Mobile (LFTO) — Cantor Fitzgerald .
Lincoln Electric (LECO) — Stifel Nicolaus set a $271.00 price target.
Lithium Americas (Argentina) (LAR) — National Bank Financial maintained its Outperform rating and lowered its price target to $11.00 from $13.00.
Live Nation Entertainment (LYV) — BTIG Research maintained its Buy rating with a $215.00 price target.
Live Nation Entertainment (LYV) — Morgan Stanley maintained its Overweight rating and raised its price target to $215.00 from $200.00.
LTC Properties (LTC) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $43.00 from $42.00.
lululemon athletica (LULU) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $90.00 from $95.00.
Lyft (LYFT) — Cantor Fitzgerald maintained its Neutral rating and lowered its price target to $15.00 from $17.00.
M&T Bank (MTB) — DA Davidson maintained its Neutral rating and lowered its price target to $258.00 from $262.00.
M&T Bank (MTB) — Morgan Stanley maintained its Overweight rating and lowered its price target to $294.00 from $301.00.
M&T Bank (MTB) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $245.00 from $255.00.
Madison Air Solutions (MAIR) — Stifel Nicolaus set a $35.00 price target.
MannKind (MNKD) — Chardan Capital initiated coverage with a Buy rating and a $10.00 price target.
MannKind (MNKD) — Chardan Capital Markets initiated coverage with a Buy rating and a $10.00 price target.
ManpowerGroup (MAN) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $58.00 from $63.00.
Marcus (MCS) — B. Riley Financial maintained its Neutral rating.
Marriott International (MAR) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $426.00 from $425.00.
Marriott Vacations Worldwide (VAC) — Wells Fargo & Company maintained its Underweight rating and lowered its price target to $100.00 from $101.00.
Marsh & McLennan Companies (MRSH) — Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $201.00 from $186.00.
Marsh & McLennan Companies (MRSH) — Mizuho maintained its Neutral rating and raised its price target to $200.00 from $190.00.
MasTec (MTZ) — Barclays maintained its Overweight rating and lowered its price target to $320.00 from $340.00.
Matador Resources (MTDR) — Mizuho maintained its Outperform rating and lowered its price target to $71.00 from $77.00.
Match Group (MTCH) — Evercore upgraded the stock from Cautious to Outperform with a $53.00 price target.
Match Group (MTCH) — Evercore ISI upgraded the stock from In-line to Outperform with a $53.00 price target.
Maze Therapeutics (MAZE) — Canaccord Genuity initiated coverage with a Buy rating and a $75.00 price target.
Maze Therapeutics (MAZE) — Canaccord Genuity Group initiated coverage with a Buy rating and a $75.00 price target.
McDonald’s (MCD) — UBS Group maintained its Buy rating.
MDxHealth (MDXH) — BTIG Research downgraded the stock from Buy to Neutral.
Meta Platforms (META) — Morgan Stanley maintained its Overweight rating and raised its price target to $820.00 from $775.00.
Methanex (MEOH) — Canadian Imperial Bank of Commerce maintained its Outperform rating with a $77.00 price target.
MGM Resorts International (MGM) — Morgan Stanley maintained its Underweight rating and lowered its price target to $29.00 from $43.00.
MGM Resorts International (MGM) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $29.00 from $48.30.
Microsoft (MSFT) — Sanford C. Bernstein maintained its Outperform rating and raised its price target to $662.00 from $660.00.
Mid-America Apartment Communities (MAA) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $131.00 from $146.00.
Monster Beverage (MNST) — Piper Sandler maintained its Overweight rating with a $50.50 price target.
Morgan Stanley (MS) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $210.00 from $215.00.
Natera (NTRA) — Canaccord Genuity Group maintained its Buy rating and raised its price target to $500.00 from $375.00.
National Health Investors (NHI) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $68.00 from $78.00.
National Healthcare Properties (NHP) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $18.00 from $19.00.
Neptune Insurance (NP) — Piper Sandler maintained its Overweight rating.
NETSTREIT (NTST) — Mizuho maintained its Outperform rating and lowered its price target to $19.00 from $20.00.
NETSTREIT (NTST) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $20.00 from $23.00.
newcleo (NWCL) — BTIG Research initiated coverage with a Neutral rating.
Newmark Group (NMRK) — Piper Sandler downgraded the stock from Overweight to Neutral with a $13.00 price target.
Newmont (NEM) — Barclays maintained its Overweight rating and lowered its price target to $123.00 from $124.00.
NextEra Energy (NEE) — Barclays set lowered its price target to $84.00 from $91.00 with a Equal Weight rating.
NiSource (NI) — Barclays maintained its Overweight rating and lowered its price target to $44.00 from $45.00.
NiSource (NI) — BMO Capital Markets maintained its Outperform rating and raised its price target to $48.00 from $45.00.
NNN REIT (NNN) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $43.00 from $47.00.
Northrim BanCorp (NRIM) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $29.00 from $30.00.
NRG Energy (NRG) — Jefferies Financial Group set a $131.00 price target.
Nucor (NUE) — Barclays maintained its Overweight rating and raised its price target to $306.00 from $295.00.
Nuvation Bio (NUVB) — Citigroup maintained its Market Outperform rating.
O-I Glass (OI) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $10.00 from $12.00.
Occidental Petroleum (OXY) — Stephens maintained its Overweight rating and raised its price target to $80.00 from $78.00.
Ocular Therapeutix (OCUL) — Needham & Company LLC maintained its Buy rating with a $18.00 price target.
OGE Energy (OGE) — Barclays downgraded the stock from Overweight to Equal Weight with a $48.00 price target.
Oklo (OKLO) — Piper Sandler maintained its Overweight rating and lowered its price target to $49.00 from $55.00.
Omega Healthcare Investors (OHI) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $46.00 from $48.00.
Ondas (ONDS) — Citigroup maintained its Market Outperform rating.
Oruka Therapeutics (ORKA) — BTIG Research maintained its Buy rating with a $151.00 price target.
Ovintiv (OVV) — Scotiabank set a $80.00 price target.
Par Pacific (PARR) — Raymond James Financial maintained its Outperform rating with a $117.00 price target.
Park Aerospace (PKE) — Citigroup maintained its Market Outperform rating.
Parker-Hannifin (PH) — Stifel Nicolaus set a $1,002.00 price target.
PayPal (PYPL) — Cleveland Research downgraded the stock from Neutral to Underperform.
PDF Solutions (PDFS) — DA Davidson maintained its Buy rating and lowered its price target to $68.00 from $74.00.
Pebblebrook Hotel Trust (PEB) — Stifel Nicolaus set a $22.00 price target.
PENN Entertainment (PENN) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $18.00 from $20.00.
PENN Entertainment (PENN) — Susquehanna maintained its Positive rating and lowered its price target to $26.00 from $30.00.
PENN Entertainment (PENN) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $22.00 from $23.00.
Phillips 66 (PSX) — Raymond James Financial maintained its Outperform rating with a $335.00 price target.
Plains All American Pipeline (PAA) — Raymond James Financial maintained its Strong-Buy rating with a $28.00 price target.
Plains GP (PAGP) — Raymond James Financial maintained its Strong-Buy rating with a $30.00 price target.
Polaris (PII) — Citigroup maintained its Neutral rating.
Polaris (PII) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $55.00 from $70.00.
Pool (POOL) — Citigroup maintained its Underperform rating.
Pool (POOL) — Longbow Research downgraded the stock from Buy to Neutral.
Primo Brands (PRMB) — Deutsche Bank Aktiengesellschaft set a $21.00 price target.
Progressive (PGR) — UBS Group maintained its Neutral rating with a $238.00 price target.
Prologis (PLD) — KeyCorp maintained its Sector Weight rating.
Prudential Financial (PRU) — Barclays maintained its Underweight rating and lowered its price target to $94.00 from $96.00.
Prudential Financial (PRU) — Morgan Stanley maintained its Underweight rating and lowered its price target to $100.00 from $105.00.
Quantum Computing (QUBT) — Rosenblatt Securities maintained its Buy rating with a $22.00 price target.
Quest Diagnostics (DGX) — UBS Group maintained its Neutral rating with a $250.00 price target.
Quoin Pharmaceuticals (QNRX) — Canaccord Genuity initiated coverage with a Buy rating and a $18.00 price target.
Quoin Pharmaceuticals (QNRX) — Canaccord Genuity Group initiated coverage with a Buy rating and a $18.00 price target.
Realty Income (O) — Mizuho maintained its Neutral rating and lowered its price target to $59.00 from $61.00.
Realty Income (O) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $59.00 from $64.00.
Recursion Pharmaceuticals (RXRX) — Needham & Company LLC maintained its Buy rating with a $8.00 price target.
Red Rock Resorts (RRR) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $59.00 from $61.00.
Red Rock Resorts (RRR) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $78.00 from $77.00.
Regeneron Pharmaceuticals (REGN) — Piper Sandler maintained its Overweight rating and raised its price target to $865.00 from $854.00.
Regions Financial (RF) — Brean Capital upgraded the stock from Neutral to Buy with a $33.00 price target.
Regions Financial (RF) — Capital One Financial set a $33.00 price target.
Regions Financial (RF) — DA Davidson maintained its Neutral rating and lowered its price target to $31.00 from $32.00.
Regions Financial (RF) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $32.00 from $34.00.
Regions Financial (RF) — Stephens maintained its Equal Weight rating and lowered its price target to $30.00 from $32.00.
Repligen (RGEN) — Canaccord Genuity Group maintained its Hold rating and raised its price target to $180.00 from $145.00.
Resideo (REZI) — Citizens initiated coverage with a Market Outperform rating and a $22.00 price target.
Resideo Technologies (REZI) — Citigroup initiated coverage with a Market Outperform rating.
Resideo Technologies (REZI) — Citizens Jmp initiated coverage with a Market Outperform rating and a $22.00 price target.
Restaurant Brands International (QSR) — Royal Bank Of Canada maintained its Neutral rating and lowered its price target to $79.00 from $80.00.
Revolution Medicines (RVMD) — Truist Financial maintained its Buy rating and raised its price target to $241.00 from $240.00.
Rigel Pharmaceuticals (RIGL) — HC Wainwright maintained its Buy rating with a $85.00 price target.
Rollins (ROL) — Canaccord Genuity Group maintained its Hold rating and lowered its price target to $36.00 from $45.00.
Rollins (ROL) — Sanford C. Bernstein maintained its Market Perform rating and lowered its price target to $35.00 from $42.00.
Rush Street Interactive (RSI) — Morgan Stanley initiated coverage with a Equal Weight rating and a $22.00 price target.
Sabra Healthcare REIT (SBRA) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $21.00 from $23.00.
SEI Investments (SEIC) — Piper Sandler maintained its Overweight rating and raised its price target to $127.00 from $120.00.
ServiceNow (NOW) — UBS Group set a $165.00 price target.
SharkNinja (SN) — JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $223.00 from $207.00.
Silence Therapeutics (SLN) — Jefferies Financial Group downgraded the stock from Buy to Hold.
Silence Therapeutics (SLN) — William Blair downgraded the stock from Outperform to Market Perform.
Silgan (SLGN) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $52.00 from $56.00.
Simmons First National (SFNC) — DA Davidson maintained its Neutral rating and raised its price target to $25.00 from $24.00.
Simmons First National (SFNC) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to $25.00 from $26.00.
Simmons First National (SFNC) — Morgan Stanley maintained its Underweight rating and raised its price target to $27.00 from $26.00.
Simmons First National (SFNC) — Robert W. Baird set a $25.00 price target.
SLB (SLB) — Citigroup maintained its Buy rating.
SLB (SLB) — Piper Sandler maintained its Overweight rating and lowered its price target to $63.00 from $64.00.
Sol-Gel Technologies (SLGL) — HC Wainwright maintained its Buy rating with a $110.00 price target.
Sonoco Products (SON) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $53.00 from $56.00.
Southern Copper (SCCO) — Barclays maintained its Underweight rating and raised its price target to $168.00 from $166.00.
SpaceX (SPCX) — Royal Bank Of Canada maintained its Outperform rating.
Sportradar Group (SRAD) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $13.50 from $15.00.
Sprouts Farmers Market (SFM) — The Goldman Sachs Group set a $94.00 price target.
Spyre Therapeutics (SYRE) — BTIG Research maintained its Buy rating with a $121.00 price target.
State Street (STT) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $185.00 from $200.00.
Steel Dynamics (STLD) — Barclays maintained its Overweight rating and raised its price target to $285.00 from $272.00.
Sun Communities (SUI) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $136.00 from $141.00.
Tesla (TSLA) — Barclays upgraded the stock from Negative to Outperform.
Tesla (TSLA) — Cantor Fitzgerald maintained its Overweight rating.
Texas Instruments (TXN) — UBS Group set a $360.00 price target.
The Goldman Sachs Group (GS) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $950.00 from $970.00.
The PNC Financial Services Group (PNC) — Truist Financial maintained its Hold rating and lowered its price target to $248.00 from $252.00.
TIC Solutions (TIC) — UBS Group maintained its Buy rating.
Toast (TOST) — Truist Financial maintained its Buy rating and lowered its price target to $38.00 from $39.00.
Tractor Supply (TSCO) — Piper Sandler maintained its Neutral rating and raised its price target to $33.00 from $31.00.
Tractor Supply (TSCO) — Truist Financial set raised its price target to $33.00 from $32.00 with a Hold rating.
Tractor Supply (TSCO) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $36.00 from $35.00.
Transdigm Group (TDG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $1,300.00 from $1,400.00.
TransUnion (TRU) — Mizuho maintained its Neutral rating and lowered its price target to $74.00 from $77.00.
Travel + Leisure (TNL) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $90.00 from $92.00.
Travelers Companies (TRV) — Deutsche Bank Aktiengesellschaft maintained its Hold rating.
Travelers Companies (TRV) — Truist Financial maintained its Buy rating and raised its price target to $435.00 from $425.00.
Travelers Companies (TRV) — UBS Group maintained its Neutral rating.
Travelers Companies (TRV) — Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $377.00 from $341.00.
TripAdvisor (TRIP) — Cantor Fitzgerald maintained its Underweight rating and lowered its price target to $8.00 from $9.00.
Truist Financial (TFC) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $54.00 from $55.00.
Truist Financial (TFC) — Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $51.00 from $53.00.
United Dominion Realty Trust (UDR) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $39.00 from $43.00.
United Therapeutics (UTHR) — Leerink Partners maintained its Outperform rating and raised its price target to $725.00 from $685.00.
United Therapeutics (UTHR) — UBS Group set a $725.00 price target.
Uranium Royalty (UROY) — HC Wainwright maintained its Buy rating with a $4.50 price target.
Uranium Royalty (UROY) — National Bank Financial maintained its Outperform rating and raised its price target to $4.00 from $3.75.
Urogen Pharma (URGN) — HC Wainwright maintained its Buy rating with a $75.00 price target.
V.F. (VFC) — UBS Group maintained its Neutral rating with a $17.00 price target.
Vale (VALE) — Scotiabank upgraded the stock from Sector Perform to Sector Outperform with a $16.00 price target.
Varonis Systems (VRNS) — Barclays downgraded the stock from Overweight to Equal Weight with a $50.00 price target.
Veeva Systems (VEEV) — Barclays maintained its Overweight rating and raised its price target to $360.00 from $315.00.
Ventas (VTR) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $96.00 from $104.00.
Veradermics (MANE) — Cantor Fitzgerald maintained its Overweight rating.
Veradermics (MANE) — Needham & Company LLC maintained its Buy rating and raised its price target to $172.00 from $164.00.
Veralto (VLTO) — Stifel Nicolaus set a $113.00 price target.
VeriSign (VRSN) — Wedbush maintained its Outperform rating and raised its price target to $351.00 from $341.00.
Vermilion Energy (VET) — Scotiabank maintained its Sector Perform rating.
VICI Properties (VICI) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $24.00 from $26.00.
Victoria’s Secret & Co. (VSXY) — Morgan Stanley maintained its Overweight rating and raised its price target to $104.00 from $101.00.
Virtus Investment Partners (VRTS) — Piper Sandler maintained its Overweight rating and lowered its price target to $146.00 from $172.00.
Vylor (VYLR) — Vertical Research downgraded the stock from Buy to Hold with a $74.00 price target.
W.P. Carey (WPC) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $73.00 from $80.00.
WaFd (WAFD) — DA Davidson set a $31.00 price target.
WaFd (WAFD) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $34.00 from $40.00.
WaFd (WAFD) — Piper Sandler maintained its Neutral rating and lowered its price target to $31.00 from $32.00.
Watts Water Technologies (WTS) — Stifel Nicolaus set a $445.00 price target.
Weatherford International (WFRD) — Piper Sandler maintained its Overweight rating and lowered its price target to $110.00 from $118.00.
WEC Energy Group (WEC) — Barclays maintained its Equal Weight rating and lowered its price target to $108.00 from $117.00.
Welltower (WELL) — Wells Fargo & Company maintained its Overweight rating and raised its price target to $268.00 from $266.00.
Whirlpool (WHR) — Longbow Research downgraded the stock from Buy to Neutral.
Wix.com (WIX) — Cantor Fitzgerald maintained its Overweight rating and raised its price target to $90.00 from $80.00.
Wynn Resorts (WYNN) — Morgan Stanley maintained its Overweight rating and lowered its price target to $120.00 from $128.00.
Wynn Resorts (WYNN) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to $125.00 from $131.00.
X-Energy (XE) — Piper Sandler maintained its Underweight rating and lowered its price target to $8.00 from $9.00.
Xylem (XYL) — Stifel Nicolaus set a $141.00 price target.
Zentalis Pharmaceuticals (ZNTL) — HC Wainwright maintained its Buy rating with a $10.00 price target.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.